This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,568,433,683 units of Procainamide 1 Gram/10 ML Vial 10ML. The contract has a ceiling value of $2,850.12 and a completion date of June 4, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, which provides...
This is a firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide procainamide 1 gram/10 mL vials. The contract has a ceiling value of $2,850.12 and an ultimate completion date of July 2, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which serves as a global pharmaceutical support vehicle to supply a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Procainamide 1 Gram/10 ML Vial 10ML. The contract has a firm fixed-price pricing type, a ceiling value of $1,425.06, and an ultimate completion date of May 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,377.45, is for the delivery of 4,564,389,989 units of Procainamide 1 gram/10 ml vials. The contract is a firm fixed-price agreement with an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that supplies a wide range of medical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,395.40, is for the delivery of Procainamide 1 gram/10 ml vials, a pharmaceutical product used for medical purposes. The contract is a Firm Fixed Price (FFP) delivery order with a performance period through June 30, 2025. It is not set aside for any specific business category....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,425.06 for the procurement of Procainamide 1 gram/10 ml vials. The contract has a period of performance through May 21, 2025 and does not include a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $2,269.62 contract is for the delivery of 4,564,138,129 units of Procainamide 1,000 mg/2 ml vials to support military treatment programs and facilities. The delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,959.60 firm-fixed-price contract is for the supply of Procainamide 1 gram/10 ml vials, a medication used to treat certain heart rhythm disorders. The contract has an ultimate completion date of May 17, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $58,846.48 firm fixed-price delivery order is for the procurement of 4,560,867,966 units of 10 mL vials of procainamide, a medication used to treat heart rhythm disorders. The contract has an ultimate completion date of June 6, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $1,851.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of 1,000 mg/10 mL syringes of the drug procainamide, a cardiac medication. The contract is a delivery order with a firm fixed price and has an ultimate completion date of July 10, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...